Publications
• Singh, S. and Muthu, M.S. (2007): Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine UK. 2 (2), 233-240. Impact Factor: 5.413
• Singh, S., Singh, J., Muthu, M.S., Balasubramaniam, J and Mishra, B. (2007): Gastroretentive drug delivery of metoclopramide Hcl: formulation and in- vitro evaluation. Current Drug Delivery. 4(4) 269-275. Impact Factor: 1.478
• Singh, S., Mahendra, K., Srivastava, A.K., Garg, A. and Muthu, M.S. (2007): Effect of permeation enhancers on the iontophoretic transport of timolol maleate through rat skin. Acta Pharmaceutica Sciencia. 49 (3), 235-252.
• Singh, S., Jain, S., Muthu, M.S and Tilak, R. (2008): Preparation and evaluation of buccal bioadhesive tablets containing clotrimazole. Current Drug Delivery. 5 (2), 133-141.Impact Factor: 1.478
• Singh, S., Jain, S., Muthu, M.S., Tiwari, S., Tilek, R. (2008): Preparation and evaluation of buccal bioadhesive films containing clotrimazole. AAPS Pharm Sci Tech. USA 9(2), 660-667. Impact Factor: 1.641
• Muthu, M.S. and Singh, S. (2008): Studies on biodegradable polymeric nanoparticles of risperidone: in-vitro and in-vivo evaluation. Nanomedicine UK. 3(3) 305-319. Impact Factor: 5.413
• Sunilson, A.J., Muthu, M.S., Mohan, M.S., Kumari, A.A.G., Thomas, J and Jeyaraj, P. (2008): Antidiabetic activity of MOMORDICA TUBEROSA (ROXB.) tuber extracts. Int J Pharmacol Biol Sci. 2(2), 41-45.
• Muthu, M.S and Singh, S. (2009): Poly (D, L-Lactide) nanosuspension of risperidone for parentral delivery: formulation and in vitro evaluation. Current Drug Delivery. 5(1),62-68. Impact Factor: 1.478
• Muthu, M.S., Singh, S. (2009): Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine UK. 4(1), 105-118. Impact Factor: 5.413
• Singh, S., Gajra, B., Muthu, M.S., Rawat, M., (2009): Enhanced transdermal delivery of ketoprofen from bioadhesive gel. Pakistan Journal of Pharmaceutical Sciences. 2(2), 193-198. Impact Factor: 0.682
• Muthu, M.S., Rawat, M.K., Mishra, A., Singh, S. (2009): PLGA nanoparticles formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine (NBM). 5(3), 323-333. (Listed in Science Direct Top 25 Hottest Articles – Rank is 15) Impact Factor: 6.155
• Muthu, M.S., Rajesh, C.V., Mishra, A., Singh, S. (2009): Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine UK. 4(6), 657-667. Impact Factor: 5.413
• Muthu, M.S. and Feng, S.S. (2009): Pharmaceutical stability aspects of nanomedicines. Nanomedicine UK. 4 (8), 857-860. Impact Factor: 5.413
• Rawat M.K., Jain A., Mishra, A., Muthu M.S., Singh, S. (2010): Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Current Drug Delivery. 7 (1), 44-50. Impact Factor: 1.478
• Muthu, M.S. and Wilson, B. (2010): Multifunctional radionanomedicine: a novel platform for effective cancer imaging and therapy. Nanomedicine UK. 5 (2), 169-171. Impact Factor: 5.413
• Singh, S., Soni, R., Rawat, M.K., Jain, A., Deshpande, S.B., Singh, S.K., and Muthu, M.S. (2010): In vitro and in vivo evaluation of buccal bioadhesive films containing salbutamol sulphate. Chem. Pharm. Bulletin. 58(3), 307-311. Impact Factor: 1.380
• Rawat, M.K., Jain, A., Mishra, A., Muthu, M.S and Singh, S. (2010): Effect of lipid matrix on characteristics of repaglinide loaded solid lipid nanoparticles for oral delivery. Therapeutic Delivery. 1(1), 63-73. PubMed Indexed
• Muthu, M.S. and Feng, S.S. (2010): Nanopharmacology of liposomes developed for cancer therapy. Nanomedicine UK. 5(7), 1017-1019. Impact Factor: 5.413
• Wilson, B., Samanta, MK., Muthu, M.S and Vinothapooshan, G. (2011): Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat alzheimer’s disease. Therapeutic Delivery. 2 (5), 599-609. PubMed Indexed
• Muthu, M.S. and Feng, S.S. (2011): Targeted nanomedicine for the detection and treatment of circulating tumour cells. Nanomedicine UK. 6 (4), 579-581. Impact Factor: 5.413
• Muthu, M.S., Kulkarni, S.A., Xiong, J and Feng, S.S. (2011): Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. International Journal of Pharmaceutics. 421 (2), 332-340. Impact Factor: 3.650
• Muthu, M.S., Kulkarni S.A., Yutao L and Feng, S.S. (2012): Development of docetaxel loaded Vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine UK. 7 (3), 353-364. Impact Factor: 5.413
• Muthu, M.S. and Wilson, B. (2012): Challenges posed by the scale-up of nanomedicines. Nanomedicine UK. 7 (3), 307-309. Impact Factor: 5.413
• Muthu, M.S., Kulkarni, S.A., Raju, A and Feng, S.S. (2012): Theranostic liposomes of TPGS coating for targeted co delivery of docetaxel and quantum dots. Biomaterials. 33, 3494-3501. Impact Factor: 8.557
• Muthu, M.S., Pandey B.L., Sahu, A.K. and Rajesh, C.V. (2012): Emerging patents for cancer-targeted nanomedicines. Pharmaceutical Patent Analyst. 1(2), 113-115. PubMed Indexed
• Muthu, M.S (2012): Focus on the development of computer-aided nanomedicine design. Nanomedicine UK. 7(10), 1471-1473. Impact Factor: 5.413
• Lanjhiyana S.K., Bajpayee P., Kesavan K., Lanjhiyana S and Muthu, M.S. (2013): Chitosan-sodium alginate blended polyelectrolyte complexes as potential multiparticulate carrier system: colon targeted delivery and gamma scintigraphic imaging. Expert Opinion on Drug Delivery. 10 (1), 5 -15. Impact Factor: 4.840
• Sahu, AK., Gautam, M.K., Deshmukh, P.T., Kushwah, L.S., Silawat, N., Akbar, Z and Muthu, M.S. (2013): Effect of embelin on lithium-induced nephrogenic diabetes insipidus in albino rats. Asian Pacific Journal of Tropical Disease. S729-S733. Scopus Indexed
• Muthu, M.S and Feng, S.S. (2013): Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. Expert Opinion on Drug Delivery. 10 (2), 151-155. Impact Factor: 4.840
• Vijayakumar M.R., Muthu, M.S. and Singh S (2013): Co-polymers of poly (lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Expert Opinion on Drug Delivery. 10 (4), 529-543. Impact Factor: 4.840
• Raju, A., Muthu, M.S. and Feng, S.S. (2013): Trastuzumab-conjugated Vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opinion on Drug Delivery. 10 (6), 747-760. Impact Factor: 4.840
• Muthu, M.S., Abdulla, A. and Pandey B.L. (2013): Major toxicities of carbon nanotubes induced by reactive oxygen species: should we worry about the effects on the lungs, liver and normal cells? Nanomedicine UK. 8 (6), 863-866. Impact Factor: 5.413
• Kesavan, K., Pandit, JK., Kant S and Muthu, M.S (2013): Positively charged microemulsions of dexamethasone: comparative effects of two co-surfactants on ocular drug delivery and bioavailability. Therapeutic Delivery. 4 (11), 1385-1395. PubMed Indexed
• Muthu, M.S, Leong D.T, Mei L and Feng, S.S. (2014): Nanotheranostics – Application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 4 (6), 660-677. Impact Factor: 8.022
• Muthu, M.S., Mei, L and Feng, S.S. (2014): Nanotheranostics: advanced nanomedicine for integration of diagnosis and therapy. Nanomedicine UK. 9 (9), 1277-1280. Impact Factor: 5.413
• Muthu, M.S., Agrawal, P and Singh, R.P. (2014): Antipsychotic nanomedicine: a successful platform for clinical use. Nanomedicine UK. 9 (14), 2401-2404. Impact Factor: 5.413
• Muthu, M.S., Kutty, R.V., Luo, Z., Xie, J and Feng, S.S. (2015): Theranostic Vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials. 39, 3494-3501. Impact Factor: 8.557
• Muthu, M.S., Sahu A.K., Sonali., Abdulla, A., Kaklotar, D., Rajesh, C.V., Sanjay, S and Pandey B.L. (2015): Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Delivery. 1-8. Impact Factor: 2.558
• Kutty, R.V., Chia, S.L., Setyawati, M.I., Muthu, M.S., Feng, S.S., Leong, D.T. (2015): In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials. 63, 58-69. Impact Factor: 8.557
• Sonali, Agrawal, P., Singh R.P., Rajesh, C.V., Sanjay, S., Vijayakumar M.R., Pandey B.L., Muthu, M.S. (2015): Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Delivery. In Press. Impact Factor: 2.558
• Muthu, M.S., Agrawal, P and Singh, S (2016): Theranostic nanomedicine of gold nanoclusters: emerging platform for cancer diagnosis and therapy. Nanomedicine UK. In Press. Impact Factor: 5.413
• Singh, R.P., Sharma, G., Sonali, Agrawal, P., Pandey B.L., Koch, B., Muthu, M.S. (2016): Transferrin receptor-targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery. International Journal of Biomacromolecules. In Press. Impact Factor: 2.890
• Singh, S., Singh, J., Muthu, M.S and Mishra, B (2006): Prolonged gastric retention: floating microspheres for oral controlled drug delivery. The Indian Pharmacist. 5 (53), 61-68.
• Pandit, J.K., Singh, S and Muthu, M.S. (2006): Controlled release formulations in neurology practice: A review. Annals of Indian Academy of Neurology. 9 (4), 207-216. Impact Factor: 0.514
• Muthu, M.S (2009): Nanoparticles based on PLGA and its co-polymer: An overview. Asian Journal of Pharmaceutics. 3(4), 266-273. Scopus Indexed
• Kumar, D., Muthu, M.S., Pandey, B.L. (2015): Pharmacovigilance Pragramme in India: current status and its Indian perspectives. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 3(3), 34-36 (contributed as Editor-in-chief).
